Shots:

• Pfizer will pay access fee for using Atomwise’s AI technology with success-based payments for each target protein selected- while Atomwise will computationally analyse various small molecules for each of Pfizer’s identified target proteins
• Additionally- Atomwise medicinal and computational chemistry team will work collaboratively with Pfizer scientists to identify potency and chemical properties of the small molecules
• Atomwise’s platform is based on AI technology to extract statistical insights from experimental affinity measurements and protein structures to predict the binding of small molecules to proteins

| Ref: Atomwise | Image: WuxiMediaGlobal